Post Exacerbation Asthma Clinic Telecare Intervention to Reduce Recurrent Exacerbations

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorTel-Aviv Sourasky Medical Center

About this trial

Asthma exacerbations leading to emergency department visits or hospitalization are associated with a high risk of recurrent exacerbations, poor disease control, and increased healthcare utilization in the months following discharge. Early specialist follow-up during this vulnerable transition period remains limited, and many patients do not receive optimized long-term asthma management. The purpose of this study is to evaluate whether a structured remote asthma clinic intervention initiated shortly after hospital discharge can reduce recurrent exacerbations and improve asthma-related outcomes compared to standard community care.

This prospective randomized study will enroll 220 adult patients (18-75 years) presenting to the emergency department at Tel Aviv Sourasky Medical Center with an asthma exacerbation. Participants will be randomly assigned to one of two groups:

1. Intervention group - will undergo two structured remote pulmonology follow-up visits via secure video consultation within 7-21 days and 5 months after discharge, including treatment optimization, inhaler technique assessment, and self-management education. 2. Control group - will continue standard community care without additional intervention.

All participants will complete scheduled follow-up assessments over 12 months, including evaluation of exacerbations, asthma control, healthcare utilization, and medication use.

Eligibility criteria

Qualifiers

Presentation to the emergency department with an asthma exacerbation.

Ability to complete telephone follow-up and access to a personal e-mail account.

Agreement to participate in the study.

Written or verbal informed consent according to study group assignment.

Disqualifiers

Uncontrolled cardiac disease.

Any other uncontrolled medical condition.

Inability to complete telephone follow-up.

Pregnancy.

Trial design

Treatments tested in this trial

  • Follow-up in a remote flare-up clinic

Treatment groups

220 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Tel-Aviv Sourasky Medical Center

Lead sponsor

The Dalia and Eli Hurvitz Foundation Grant

Collaborator